Hegseth's plan to screen military members for low testosterone raises concern for doctors: "Not a performance drug"
Defense Secretary Pete Hegseth's plan to screen military personnel for testosterone levels has drawn criticism from medical experts. Doctors argue that testosterone is not a performance-enhancing drug and that routine screening is not medically recommended.
Why it matters
The policy highlights a potential conflict between political directives regarding military readiness and established medical standards for health screenings.
A day after Defense Secretary Pete Hegseth announced that U.S. service members over the age of 30 will be annually screened for "testosterone deficiency," doctors are expressing skepticism of the program and its goals. Hegseth said all service members over 30 will be screened as part of their regular health assessments, and that younger ones will have the option of being tested to ensure that they "have the right testosterone levels to operate at your absolute best." If they are recommended for treatment, they'll have the option to receive testosterone replacement therapy. Hegseth has commented frequently on the physical standards of the military, connecting appearance and masculinity to combat readiness. Hegseth did not say what the new policy might mean for female service members, and other details have not yet been announced.Doctors flagged a range of concerns about the policy, which is likely to be costly to implement.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in